Michael T. Byrne, DO | Authors

Articles

What Is the Indication for Sorafenib in Hepatocellular Carcinoma? A Clinical Challenge

March 15, 2011

In this review article we will discuss the current data on, and future role of, sorafenib in the treatment of hepatocellular carcinoma beyond Child-Pugh A cirrhosis, in conjunction with local therapy, and in a transplant setting.